Health and Fitness Health and Fitness
Mon, December 22, 2008
[ 11:15 AM ] - Market Wire
Emeritus Closes on Agreement to Purchase Five Communities
[ 11:02 AM ] - Market Wire
EPIX Pharmaceuticals Announces FDA Approval of Vasovist (gadofosveset trisodium)
[ 10:16 AM ] - Market Wire
Resumen: ReGen Biologics obtiene aprobacin 510(K) .. o de andamiaje de colgeno: el implante de menisco
[ 10:07 AM ] - Market Wire
Samenvatting: ReGen Biologics krijgt toestemming .. steigerwerk met de naam Menaflex Collagen Meniscu
[ 07:40 AM ] - Market Wire
Remedents GlamSmile Takes Off in Australia
[ 06:00 AM ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Expands Board With Addition of John H. Landon
[ 05:15 AM ] - Market Wire
Vicor Technologies, Inc.: Vicor Technologies Announces Appointment of Chief Accounting Officer
[ 05:00 AM ] - Market Wire
Theravance, Inc.: GSK and Theravance Announce Pos .. BA '444 in the Treatment of COPD in the Horizon D
[ 04:43 AM ] - Market Wire
RegeneRx Updates Schedule for Release of Clinical Trial Information
[ 04:40 AM ] - Market Wire
St. Jude Medical Acquires MediGuide
[ 04:30 AM ] - Market Wire
Health Net, Inc. Fourth Quarter and Year-End 2008 Earnings Conference Call
[ 04:30 AM ] - Market Wire
ReGen Biologics erhlt 510(K)-Zulassung der FDA fr .. , das Collagen-Meniskus-Implantat (CMI) Menaflex"
[ 04:30 AM ] - Market Wire
ReGen Biologics reoit de la FDA l'autorisation de .. r son dispositif d'chafaudage de collagne, l'impl
[ 04:30 AM ] - Market Wire
ReGen Biologics Receives FDA 510(K) Clearance for .. d Device: The Menaflex" Collagen Meniscus Implant
[ 04:30 AM ] - Market Wire
Riassunto: ReGen Biologics riceve l'autorizzazion .. sitivo-scaffold in collagene: il Menaflex" Collag
[ 04:30 AM ] - Market Wire
Life Technologies' Solutions Enable Tissue-Engineered Transplant
[ 04:18 AM ] - Market Wire
NPS Pharmaceuticals Initiates Phase 3 'REPLACE' Study of NPSP558 in Hypoparathyroidism
[ 04:03 AM ] - Market Wire
NovaDel Pharma Receives FDA Approval of Zolpimist"
[ 04:00 AM ] - Market Wire
King Extends Tender Offer for Alpharma
[ 04:00 AM ] - Market Wire
Biovail Enters into Commercial Alliance for Aplenzin"
[ 04:00 AM ] - Market Wire
Massachusetts General Hospital and Idera Pharmace .. esearch Grant from Massachusetts Life Sciences Ce
[ 03:30 AM ] - Market Wire
Flamel Technologies AnnouncesNew Micropump and Me .. ntracts, and a Research Collaboration with Pfizer
[ 03:30 AM ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Announce .. hase 2 Clinical Trial Using SCV-07 to Prevent Ora
[ 03:30 AM ] - Market Wire
Myriad Genetics: Myriad Genetics Launches Sixth P .. edicine Product, Prezeon -- to Reveal PTEN Status
[ 03:00 AM ] - Market Wire
Abiomed Appoints Robert L. Bowen as Chief Financial Officer
[ 02:00 AM ] - Market Wire
Transcend Announces Acquisition of Deventure Health Partners
Sun, December 21, 2008
[ 11:07 PM ] - Market Wire
SCOR: SCOR receives Life Retakaful licence
Fri, December 19, 2008
[ 01:52 PM ] - Market Wire
Healthways Among First in the Nation to Achieve A .. rehensive Wellness Standards and Measures Program
[ 12:34 PM ] - Market Wire
PhotoMedex Announces Annual Stockholders Meeting
[ 12:17 PM ] - Market Wire
Richmond Minerals Inc.: Richmond Minerals Inc. Announces No Material Change

Richmond Minerals Inc.: Richmond Minerals Inc. Announces No Material Change


Published on 2008-12-19 13:14:39, Last Modified on 2008-12-19 13:14:49 - Market Wire
  Print publication without navigation


TORONTO, ONTARIO--(Marketwire - Dec. 19, 2008) - Richmond Minerals Inc. (TSX VENTURE:RMD) reports today that there are no corporate developments or undisclosed material changes involving the Corporation to account for its recent rise in stock price.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release.


Contributing Sources